sb 203580 has been researched along with sb 216763 in 5 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 342 | 0 | 225 |
Protein | Taxonomy | sb 203580 (IC50) | sb 216763 (IC50) |
---|---|---|---|
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.55 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.55 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.55 | |
Cyclin-A2 | Homo sapiens (human) | 0.269 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.269 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0477 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0342 | |
Cyclin-A1 | Homo sapiens (human) | 0.269 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.55 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Albrecht, W; Ansideri, F; Döring, E; Haun, U; Heider, F; Koch, P; Kudolo, M; Laufer, SA; Pantsar, T; Poso, A; Tesch, R | 1 |
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
Choi, SE; Jang, HJ; Kang, Y; Kim, DJ; Kim, HE; Kim, HJ; Kim, HS; Lee, KW; Shin, HC | 1 |
Hao, C; Jiang, Y; Li, J; Ma, N; Xu, Z; Yin, L | 1 |
5 other study(ies) available for sb 203580 and sb 216763
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors.
Topics: Amino Acid Sequence; Carbon-13 Magnetic Resonance Spectroscopy; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Inhibitory Concentration 50; Molecular Docking Simulation; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proton Magnetic Resonance Spectroscopy; Pyridines; Sequence Homology, Amino Acid; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2019 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.
Topics: Adenoviridae; Anthracenes; Apoptosis; Caspase 3; Cell Cycle; Cells, Cultured; Cytosol; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Fumonisins; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Indoles; Lithium Chloride; Maleimides; Mitochondria; Palmitates; Phosphorylation; Phosphoserine; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Pyridines; Thiadiazoles; Transduction, Genetic; Umbilical Veins | 2007 |
Effects of signaling pathway inhibitors on hematopoietic stem cells.
Topics: Animals; Cell Differentiation; Cell Self Renewal; Female; Glycogen Synthase Kinase 3 beta; Hematopoietic Stem Cells; Histone Deacetylase Inhibitors; Imidazoles; Indoles; Maleimides; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |